99 related articles for article (PubMed ID: 2468412)
41. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
[TBL] [Abstract][Full Text] [Related]
42. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
43. A monoclonal antibody against a synthetic peptide is specific for the free native human chorionic gonadotropin beta-subunit.
Bellet D; Bidart JM; Jolivet M; Tartar A; Caillaud JM; Ozturk M; Strugo MC; Audibert F; Gras-Masse H; Assicot M
Endocrinology; 1984 Jul; 115(1):330-6. PubMed ID: 6203726
[TBL] [Abstract][Full Text] [Related]
44. Antiidiotype antibodies in cancer patients receiving monoclonal antibody to carcinoembryonic antigen.
Traub UC; DeJager RL; Primus FJ; Losman M; Goldenberg DM
Cancer Res; 1988 Jul; 48(14):4002-6. PubMed ID: 3289737
[TBL] [Abstract][Full Text] [Related]
45. Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.
Muto MG; Lepisto EM; Van den Abbeele AD; Knapp RC; Kassis AI
Am J Obstet Gynecol; 1989 Nov; 161(5):1206-12. PubMed ID: 2686446
[TBL] [Abstract][Full Text] [Related]
46. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
47. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA 102: whole IgG versus F(ab')2 fragments].
Wada K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):266-73. PubMed ID: 1513308
[TBL] [Abstract][Full Text] [Related]
48. [Concentration of carcinoembryonic antigen, alpha-fetoprotein and beta-subunit of human chorionic gonadotropin in serum of workers employed directly in the production of coke].
Snit M
Med Pr; 1993; 44(1):21-8. PubMed ID: 7684110
[TBL] [Abstract][Full Text] [Related]
49. [Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein or anti-carcinoembryonic antigen monoclonal antibodies].
Konno H
Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):365-74. PubMed ID: 2423862
[TBL] [Abstract][Full Text] [Related]
50. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
Beyers M; Aspinall S; Conradie JD; Fourie PJ
Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
[TBL] [Abstract][Full Text] [Related]
51. Design of peptides with improved affinities for anti-human chorionic gonadotropin monoclonal antibodies.
van Amerongen A; Plasman HH; Kuperus D; Kremer L; Rodriguez-Frade JM; Albar JP; Llopis R; Schaaper WM; Meloen RH
Pept Res; 1994; 7(2):83-90. PubMed ID: 8012125
[TBL] [Abstract][Full Text] [Related]
52. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
[TBL] [Abstract][Full Text] [Related]
53. Tumor markers for cancer detection. I.
Pluygers EP; Beauduin MP; Baldewyns PE; Burion JA
Cancer Detect Prev; 1986; 9(5-6):495-504. PubMed ID: 2430704
[TBL] [Abstract][Full Text] [Related]
54. Preparation and characterization of antibodies to the urinary fragment of the human chorionic gonadotropin beta-subunit.
Krichevsky A; Armstrong EG; Schlatterer J; Birken S; O'Connor J; Bikel K; Silverberg S; Lustbader JW; Canfield RE
Endocrinology; 1988 Jul; 123(1):584-93. PubMed ID: 2454812
[TBL] [Abstract][Full Text] [Related]
55. [CA-12 tumor marker values in serum following radioimmuno-scintigraphy].
Barrada M; Pateisky N; Schatten C; Philipp K; Sevelda P; Vavra N
Gynakol Rundsch; 1990; 30 Suppl 1():72-3. PubMed ID: 2079306
[No Abstract] [Full Text] [Related]
56. Diagnosis of cancer using microchip-based system for simultaneous quantitation of six tumor markers.
Ryabykh TP; Sokolova ZA; Paklin NB; Osipova TV
Dokl Biochem Biophys; 2011; 437():98-101. PubMed ID: 21590386
[No Abstract] [Full Text] [Related]
57. Report of BACR workshop on monoclonal antibodies in breast and ovarian cancer, Brasenose College, Oxford March 17-19th 1991.
Leonard RC; Fisken J; Roulston JE
Br J Cancer; 1991 Oct; 64(4):796-7. PubMed ID: 1911231
[No Abstract] [Full Text] [Related]
58. [Tumor localization with radiolabeled antibodies and treatment of cancer with antiserum].
Hirai H
Radioisotopes; 1984 Jul; 33(7):474-83. PubMed ID: 6209755
[No Abstract] [Full Text] [Related]
59. [Value of serum tumor markers for the early diagnosis of neoplasm and in health exams for asymptomatic persons].
Bernabé Caro R; Moreno Nogueira JA
Rev Clin Esp; 2002 Apr; 202(4):212-4. PubMed ID: 12003731
[No Abstract] [Full Text] [Related]
60. Monoclonal antibodies in the management of ovarian cancer. A clinical perspective.
Rubin SC
Cancer; 1993 Feb; 71(4 Suppl):1602-12. PubMed ID: 8431896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
